SCHEMBL14239264

SCHEMBL14239264

CCOC(=O)c1cc(-c2ccc(N)cc2F)on1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
PRKCZ Q05513 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ACR P10323 1/20 0.43
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOA P21397 1/20 0.42
ALDH1A1 P00352 5/20 0.42
ACKR3 P25106 1/20 0.41
TP53 P04637 3/20 0.41
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
CFTR P13569 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29775892 0.87 ACKR3 (0.49) MAPTL3MBTL1ACRALDH1A1ACKR3
SCHEMBL2032412 0.87 ACKR3 (0.49) MAPTL3MBTL1ACRALDH1A1ACKR3
SCHEMBL29775738 0.85 L3MBTL1 (0.53) MAPTL3MBTL1ACRALDH1A1TP53
SCHEMBL16111931 0.85 L3MBTL1 (0.53) MAPTL3MBTL1ACRALDH1A1TP53
SCHEMBL21047410 0.83 L3MBTL1 (0.47) MAPTL3MBTL1ACRLMNACYP1A2
SCHEMBL21523795 0.83 MAPT (0.51) MAPTL3MBTL1ACRLMNACYP1A2
SCHEMBL29775653 0.83 L3MBTL1 (0.47) MAPTL3MBTL1ACRLMNACYP1A2
SCHEMBL14167735 0.82 TP53 (0.51) MAPTL3MBTL1ACRLMNAALDH1A1
SCHEMBL21523692 0.80 SCD5 (0.48) MAPTL3MBTL1ACRLMNACYP1A2
SCHEMBL26923955 0.80 L3MBTL1 (0.47) MAPTL3MBTL1ACRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012168315-A1 SUBSTITUTED PIPERIDINES AS GPR119 MODULATORS FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-13 WO disclosed